Progesterone promotes immunomodulation and tumor development in the murine mammary gland

BACKGROUND: Clinical studies have linked usage of progestins (synthetic progesterone [P4]) to breast cancer risk. However, little is understood regarding the role of native P4, signaling through the progesterone receptor (PR), in breast tumor formation. Recently, we reported a link between PR and im...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Werner, Lauryn R, Gibson, Katelin A, Goodman, Merit L, Helm, Dominika E, Walter, Katherine R, Holloran, Sean M, Trinca, Gloria M, Hastings, Richard C, Yang, Howard H, Hu, Ying, Wei, Junping, Lei, Gangjun, Yang, Xiao-Yi, Madan, Rashna, Molinolo, Alfredo A, Markiewicz, Mary A, Chalise, Prabhakar, Axelrod, Margaret L, Balko, Justin M, Hunter, Kent W, Hartman, Zachary C, Lange, Carol A, Hagan, Christy R
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Basic Tumor Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103939/
https://ncbi.nlm.nih.gov/pubmed/33958486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001710
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars